Mathieu Gauthé

Phase III Study of¹⁸F-PSMA-1007 Versus¹⁸F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study

Anne‐Laure Giraudet, Andrea Skanjeti, C. Merlin et al. · Journal of Nuclear Medicine · 2022 · 55 citations · Full text

Medicine, Nuclear Medicine, Urology +17

Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer

Mathieu Gauthé, Marion Richard‐Molard, Juliette Fayard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 51 citations

Medicine, Oncology, Molecular Imaging +16

68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

Aloÿse Fourquet, Cyrielle Aveline, Olivier Cussenot et al. · Scientific Reports · 2020 · 42 citations · Full text

Medicine, Nuclear Medicine, Urology +17

Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours

M. Paquet, Mathieu Gauthé, Jules Zhang-Yin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 40 citations

Medicine, Nuclear Medicine, Radiology +17

¹⁸F‐fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism

Mathieu Gauthé, Anne Dierick‐Gallet, Thierry Delbot et al. · World Journal of Surgery · 2020 · 32 citations

Medicine, Nuclear Medicine, Radiology +16